Application of machine learning in predicting medication adherence of patients with cardiovascular diseases: a systematic review of the literature

M. Zakeri, S. Sansgiry, S. Abughosh
{"title":"Application of machine learning in predicting medication adherence of patients with cardiovascular diseases: a systematic review of the literature","authors":"M. Zakeri, S. Sansgiry, S. Abughosh","doi":"10.21037/jmai-21-26","DOIUrl":null,"url":null,"abstract":"Background: Cardiovascular disease (CVD) is among the most common chronic diseases in the US. Adequate controlling CVD risk factors with medications can have a significant impact on patients’ long-term outcome. Early identification of patients with low adherence to medications using predictive models through machine learning (ML) may enhance outcomes of patients with CVD. The objective of the current review was to systematically identify and summarize published predictive models that used ML to assess medication adherence (MA) among patients with chronic CVD [heart failure (HF) and coronary artery disease (CAD)] or their main risk factors [hypertension (HTN) and hypercholesterolemia (HCL)]. Methods: A targeted review of English literature was undertaken in PubMed and Google Scholar from January 1, 2000 to August 9, 2021. All studies that used ML to predict MA among patients with chronic CVD or their main risk factors were eligible for this review. Risk of bias was assessed based on the studies’ sample size, data analysis methods, variables in each model, and validation methods used. Characteristics and outcomes of each study were summarized in tables. Results: A total of 12 studies met the eligibility criteria. Selected studies evaluated MA among patients with HF (n=2), CAD (n=3), HTN (n=5), and HCL (n=2). The most used ML algorithms used were random forest (RF) (n=5), support vector machine (SVM) (n=4), and neural network (NN) (n=4). The accuracy of the models ranged from 0.53 to 0.97. Discussion: Most studies used cross-validation to evaluate the internal validation of the model. However, none of the models were externally validated using a different dataset. Using ML to predict MA among patients with CVD and their risk factors is relatively new with only a few studies identified. Compared to conventional statistical methods, fewer restrictions for inclusion of variables in ML models, may enhance the model performance. More research is required to predict MA with higher accuracy and external validity.","PeriodicalId":73815,"journal":{"name":"Journal of medical artificial intelligence","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of medical artificial intelligence","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21037/jmai-21-26","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Cardiovascular disease (CVD) is among the most common chronic diseases in the US. Adequate controlling CVD risk factors with medications can have a significant impact on patients’ long-term outcome. Early identification of patients with low adherence to medications using predictive models through machine learning (ML) may enhance outcomes of patients with CVD. The objective of the current review was to systematically identify and summarize published predictive models that used ML to assess medication adherence (MA) among patients with chronic CVD [heart failure (HF) and coronary artery disease (CAD)] or their main risk factors [hypertension (HTN) and hypercholesterolemia (HCL)]. Methods: A targeted review of English literature was undertaken in PubMed and Google Scholar from January 1, 2000 to August 9, 2021. All studies that used ML to predict MA among patients with chronic CVD or their main risk factors were eligible for this review. Risk of bias was assessed based on the studies’ sample size, data analysis methods, variables in each model, and validation methods used. Characteristics and outcomes of each study were summarized in tables. Results: A total of 12 studies met the eligibility criteria. Selected studies evaluated MA among patients with HF (n=2), CAD (n=3), HTN (n=5), and HCL (n=2). The most used ML algorithms used were random forest (RF) (n=5), support vector machine (SVM) (n=4), and neural network (NN) (n=4). The accuracy of the models ranged from 0.53 to 0.97. Discussion: Most studies used cross-validation to evaluate the internal validation of the model. However, none of the models were externally validated using a different dataset. Using ML to predict MA among patients with CVD and their risk factors is relatively new with only a few studies identified. Compared to conventional statistical methods, fewer restrictions for inclusion of variables in ML models, may enhance the model performance. More research is required to predict MA with higher accuracy and external validity.
机器学习在预测心血管疾病患者服药依从性中的应用:文献系统综述
背景:心血管疾病(CVD)是美国最常见的慢性疾病之一。通过药物充分控制CVD风险因素会对患者的长期预后产生重大影响。通过机器学习(ML)使用预测模型早期识别药物依从性低的患者可能会提高CVD患者的预后。本综述的目的是系统地识别和总结已发表的预测模型,这些模型使用ML来评估慢性CVD[心力衰竭(HF)和冠状动脉疾病(CAD)]患者的药物依从性(MA)或其主要危险因素[高血压(HTN)和高胆固醇血症(HCL)]。方法:2000年1月1日至2021年8月9日,PubMed和Google Scholar对英语文献进行了有针对性的综述。所有使用ML预测慢性CVD患者MA或其主要风险因素的研究都符合本综述的条件。根据研究的样本量、数据分析方法、每个模型中的变量和使用的验证方法来评估偏倚风险。各研究的特点和结果汇总在表格中。结果:共有12项研究符合资格标准。选定的研究评估了HF(n=2)、CAD(n=3)、HTN(n=5)和HCL(n=2中)患者的MA。使用最多的ML算法是随机森林(RF)(n=5)、支持向量机(SVM)(n=4)和神经网络(NN)(n=4)。模型的准确度在0.53到0.97之间。讨论:大多数研究使用交叉验证来评估模型的内部验证。然而,没有一个模型使用不同的数据集进行外部验证。使用ML预测CVD患者的MA及其风险因素相对较新,只有少数研究确定。与传统的统计方法相比,ML模型中包含变量的限制较少,可以提高模型性能。需要更多的研究来预测具有更高准确性和外部有效性的MA。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.30
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信